
Sign up to save your podcasts
Or
Dr. Jay Duker speaks about the results of the DAVIO trial which was a phase 1 trial investigating an intravitreal implant (EYP-1901) containg vorolanib (a VEGF and receptor blocker) in a bioerodible Durasert implant for the treatment of wet AMD.
4.4
1111 ratings
Dr. Jay Duker speaks about the results of the DAVIO trial which was a phase 1 trial investigating an intravitreal implant (EYP-1901) containg vorolanib (a VEGF and receptor blocker) in a bioerodible Durasert implant for the treatment of wet AMD.
43 Listeners
17 Listeners
5 Listeners
442 Listeners
20 Listeners
10 Listeners
50 Listeners
10 Listeners
1 Listeners
18 Listeners
16 Listeners
0 Listeners
16 Listeners
0 Listeners
0 Listeners